Abstract
Clinicians and research scientists alike have for years utilized the immune response to generate antibodies to probe physiologic and biochemical systems. Polyclonal antibody found in the course of the humoral response to an antigen may detect, quantify, and localize small amounts of material in complex mixtures. Were it not for the heterogeneity and unpredictability of the immune reponse, immunologic assays might have had an even greater application. With the introduction of somatic cell fusion most of the problems associated with polyclonal antisera and their application to basic and clinical questions are likely to be overcome.
This work was supported by NIH grant HL-19529, NCI grant //CA-17393, USPH grant AM-16791, and the Specialized Center for Research in Ischemic Heart Disease grant #HL-26215.
Dr. Mudgett-Hunter is a recipient of Established Investigator Award #79-189 from the American Heart Association.
Dr. Budzik is a recipient of the Charles A. King Trust Fellowship, Medical Research Foundation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kohler, G., Milstein, C 1975. Continuous cultures of fused cells secreting antibody of pre-defined specificity. Nature 256: 495–497.
Yelton, D. E., Scharff, M. D 1981. Monoclonal antibodies: A powerful new tool in biology and medicine. Ann. Rev. Biochem. 50: 657–680.
Hoffman, B. F., J. T. Bigger, Jr. 1980. Digitalis and allied cardiac glycosides. In The Pharmacological Basis of Therapeutics. 6th edition. ( A. G. Gilman, Y. S. Goodman, and A. Gilman, Eds.) MacMillan, New York. pp 729–760.
Smith, T. W., E. Haber 1973. Digitalis. New Engl. J. Med. 289:945, 1010, 1063, 1125.
Smith, T. W., V. P. Butler, Jr., E. Haber. 1969. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. New Engl. J. Med. 281: 1212–1216.
Mudgett-Hunter, M., M. N. Margolies, A. Ju, E. Haber. 1982. High affinity monoclonal antibodies to the cardiac glycoside digoxin. J. Immunol., (in press).
Smith, T. W 1972. Ouabain-specific antibodies: Immunochemical properties and reversal of NA+, K+-activated adenosine triphosphatase inhibition. J. Clin. Invest. 51: 1583–1593.
Nisonoff, A., Pressman, D 1958. Heterogeneity and average combining constants of antibodies from individual rabbits. J. Immunol. 80: 417–428.
Novotny, J., Mudgett-Hunter, M., Haber, E., Margolies, M. N 1981. Primary structure of a mouse antidigoxin hybridoma antibody. Fed. Proc. 40: 1098.
Schwartz, A., G. E. Lindenmayer, J. C. Allen. 1975. The sodium-potassium adenosine triphosphatase: Pharmacological, physiological and biochemical aspects. Pharmacol. Rev. 27: 3–134.
Smith, T. W., E. Haber, L. Yeatman, V. P. Butler, Jr. 1976. Reversal of advanced digoxin intoxication with Fab fragments of digoxinspecific antibodies. New Eng. J. Med. 294: 797–800.
Burchiel, S. W., B. A. Khaw, B. G. Rhodes, T. W. Smith, E. Haber. 1981. Immunopharmacokinetics and radiolabeled antibodies and their fragments. In Tumor Imaging: Radioimmunochemical Detection of Cancer. Edited by S. W. Burchiel, B. A. Rhodes, and B. Friedman. Masson, New York.
Margolies, M. N., M. Mudgett-Hunter, J. Novotny, E. Haber 1981. Monoclonal antibodies directed against the cardiac glycoside digoxin. In Monoclonal Antibodies and T Cell Hybridomas. ( G. Hammerling, U. Hammerling, and J.F. Kearney, Eds.) Elsevier, New York.
Jost, A 1946. Sur la différenciation sexuelle de l’embryon de lapin experiences de paraboise. CR Soc. Biol. 140: 463–464.
Jost, A 1946. Sur la différenciation sexuelle de l’embryon de lapin remarques au sujet de certaines operations chirurgical. CR Soc. Biol. 140: 460–462.
Jost, A 1947. Sur les derives mulleriens d’embryons de lapin des deus sexes castres a 21 jours. CR Soc. Biol. 141: 135–136.
Donahoe, P. K., D. A. Swann, A. Hayashi, M. D. Sullivan. 1979. Mullerian duct regression in the embryo correlated with cytotoxic activity against a human ovarian cancer. Science 205: 913–915.
Donahoe, P. K., A. F. Fuller, Jr., R. E. Scully, S. R. Guy, G. P. Budzik. 1981. Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice. Ann. Surg. 194: 472–480.
Fuller, A. F. Jr., S. R. Guy, G. P. Budzik, P. K. Donahoe. 1982. Mullerian inhibiting substance inhibits colony growth of a human ovarian cancer cell line. J. Clin. Endo. Metab. 54: 1051–1055.
Donahoe, P. K., G. P. Budzik, R. L. Trelstad, M. Mudgett-Hunter, A.F. Fuller, Jr., J. M. Hutson, H. Ikawa, A. Hayashi, D.T. MacLaughlin. 1982. Mullerian inhibiting substance: An update. In Recent Progress in Hormone Research, Vo. 38. ( R.O. Greep, Ed.), New York: Academic Press, pp 279–330.
Mudgett-Hunter, M., G. P. Budzik, M. Sullivan, P. K. Donahoe. 1982. Monoclonal antibody to mullerian inhibiting substance. J. Immunol. 128: 1327–1333.
Donahoe, P. K., Y. Ito, S. Marfatia, W. H. Hendren 1977. A graded organ culture assay for the detection of Mullerian inhibiting substance. J. Surg. Res. 23: 141–148.
Finger, J. M., Choo, K. H. 1981. Double-label reductive methylation of tissue proteins for precision two-dimensional polyacrylamide-gel electrophoretic analysis. Biochem. J. 193: 371–374.
Blanchard, M., Josso, N. 1974. Sources of the anti- Mullerian hormone synthesized by the fetal testis: Mullerian inhibiting activity of fetal bovine Sertoli cells in tissue culture. Ped. Res. 8: 968–971.
Price, J. M 1979. The secretion of Mullerian inhibiting substance by culture isolated Sertoli cells of the neonatal calf. Am. J. Anat. 156: 147–157.
Pierce, J.G., Parsons, T. F. 1981. Glycoprotein hormones: Structure and function. Ann. Rev. Biochem. 50: 465–495.
Ridgeway, E. C., L. J. Ardisson, M. J. Meskell, Mudgett-Hunter, M 1982. Monoclonal antibody to human thyrotropin. J. Clin. Endo. Metab. 55: 44–48.
Khaw, B. A., G. A. Beller, E. Haber, Smith, T. W 1976. Localization of cardiac myosin-specific antibody in myocardial infarction. J. Clin. Invest. 58: 439–446.
Khaw, B. A., G. A. Beller, Haber, E. 1978. Experimental myco-cardial infarct imaging following intravenous administration of Iodine-131 labeled antibody (Fabf)2 fragments specific for cardiac myosin. Circulation. 57: 743–750.
Khaw, B.A., J.T. Fallon, H.W. Strauss, E. Haber 1980. Myocardial infarct imaging with Indium-111-diethylene triamine pentaacetic acid-anticanine cardiac myosin antibodies. Science. 209: 295–297.
Khaw, B. A., J. T. Fallon, H. Katus, D. Elmaleh, H. W. Strauss, E. Locke, G. M. Pohost, E. Haber 1979. Positron imaging of experimental myocardial infarction with 68Ga-DTPA-antimyosin antibody. Circulation. 59 and 60 (Suppl II): 139.
Khaw, B. A., H. W. Strauss, A. Carvalho, E. Locke, H. K. Gold, E. Haber. Labeling anti-cardiac myosin Fab and human fibrinogen with Technetium-99m. J. Nucl. Med. (submitted for publication).
Wands, J. R., Zurawski, V. R 1981. High affinity monoclonal antibodies to hepatitis B surface antigen produced by somatic cell hybrids. Gastroent. 80: 225–232.
Porter, R. R 1959. The hydrolysis of rabbit gamma-globulin and antibodies with crystalline papain. Biochem. J. 73: 119–126.
Ey, P.L., S. J. Prowse, C. R. Jenkin. 1978. Isolation of pure IGGL, IGG2A and IGG2B immunoglobulins from mouse serum using protein A Sepharose. Immunochem. 15: 429–436.
Krejcarek, G. E., Tucker, K.L 1977. Covalent attachment of chelating groups to macromolecules. Biochem. Biophys. Res. Comm. 77: 582–585.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Mudgett-Hunter, M. et al. (1983). Monoclonal Antibodies as Physiologic Probes. In: Hollaender, A., et al. Basic Biology of New Developments in Biotechnology. Basic Life Sciences. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4460-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4460-5_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4462-9
Online ISBN: 978-1-4684-4460-5
eBook Packages: Springer Book Archive